.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
US Army
Boehringer Ingelheim
Citi
McKesson
Baxter
Argus Health
US Department of Justice
Healthtrust
QuintilesIMS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072253

« Back to Dashboard

NDA 072253 describes OXAZEPAM, which is a drug marketed by Actavis Elizabeth, Am Therap, Anda Repository, Ivax Sub Teva Pharms, Mylan, Sandoz, Watson Labs, Watson Labs Teva, Parke Davis, and Sun Pharm Industries, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the OXAZEPAM profile page.

The generic ingredient in OXAZEPAM is oxazepam. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxazepam profile page.

Summary for 072253

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 072253

Ingredient-typeBenzodiazepines

Medical Subject Heading (MeSH) Categories for 072253

Suppliers and Packaging for NDA: 072253

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAZEPAM oxazepam CAPSULE;ORAL 072253 ANDA Actavis Pharma, Inc. 0228-2073 0228-2073-10 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0228-2073-10)
OXAZEPAM oxazepam CAPSULE;ORAL 072253 ANDA Aphena Pharma Solutions - Tennessee, Inc. 43353-074 43353-074-30 30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (43353-074-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Apr 14, 1988TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Apr 14, 1988TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength15MG
Approval Date:Apr 14, 1988TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
McKesson
Teva
Fuji
McKinsey
Medtronic
Harvard Business School
Farmers Insurance
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot